Jerome B. Zeldis

248 total papers · 21.5k total citations
202 papers, 15.4k citations indexed

About

Jerome B. Zeldis is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jerome B. Zeldis has authored 202 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Hematology, 74 papers in Oncology and 70 papers in Molecular Biology. Recurrent topics in Jerome B. Zeldis's work include Multiple Myeloma Research and Treatments (103 papers), Cancer Treatment and Pharmacology (48 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Jerome B. Zeldis is often cited by papers focused on Multiple Myeloma Research and Treatments (103 papers), Cancer Treatment and Pharmacology (48 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Jerome B. Zeldis collaborates with scholars based in United States, Greece and Switzerland. Jerome B. Zeldis's co-authors include Robert Knight, Zhinuan Yu, Marta Olesnyckyj, David S. Siegel, Bart Barlogie, Elias Anaissie, John Patin, Raman Desikan, Nikhil C. Munshi and Dan Ayers and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jerome B. Zeldis

199 papers receiving 14.9k citations

Hit Papers

normalize citations (0→100%) normalize lifespan (0→100%) sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 2.0k citations Seema Singhal, Jayesh Mehta et al. New England Journal of Medicine profile →
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

2007 1.1k citations Meletios Α. Dimopoulos, Andrew Spencer et al. New England Journal of Medicine profile →
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

2007 921 citations Donna M. Weber, Christine Chen et al. New England Journal of Medicine profile →
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

2006 890 citations Alan F. List, Gordon W. Dewald et al. New England Journal of Medicine profile →
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

2002 632 citations Paul G. Richardson, Robert Schlossman et al. Blood profile →
Efficacy of Lenalidomide in Myelodysplastic Syndromes

2005 613 citations Alan F. List, S. Kurtin et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jerome B. Zeldis	10.1k	7.8k	5.5k	3.4k	1.6k	202	15.4k
Raymond Alexanian	10.5k 1.0×	7.1k 0.9×	6.0k 1.1×	3.2k 1.0×	409 0.3×	226	14.3k
Magnus Björkholm	5.7k 0.6×	5.1k 0.6×	4.0k 0.7×	4.8k 1.4×	1.5k 0.9×	489	16.3k
Guido Tricot	16.0k 1.6×	10.9k 1.4×	7.9k 1.4×	3.3k 1.0×	954 0.6×	462	22.2k
Michèle Cavo	11.5k 1.1×	7.7k 1.0×	6.7k 1.2×	2.2k 0.7×	432 0.3×	559	14.6k
Brian G.M. Durie	11.5k 1.1×	8.6k 1.1×	7.8k 1.4×	1.9k 0.6×	307 0.2×	288	15.5k
Richard J. Jones	7.7k 0.8×	3.3k 0.4×	4.3k 0.8×	2.3k 0.7×	651 0.4×	333	14.4k
Stanley Cohen	4.7k 0.5×	3.2k 0.4×	3.9k 0.7×	2.3k 0.7×	950 0.6×	214	18.3k
Ferdinand C. Breedveld	5.4k 0.5×	2.2k 0.3×	2.3k 0.4×	2.6k 0.8×	1.2k 0.8×	182	21.9k
Orhan Sezer	3.8k 0.4×	4.6k 0.6×	5.1k 0.9×	1.1k 0.3×	885 0.6×	171	10.9k
Seema Singhal	7.0k 0.7×	4.6k 0.6×	4.0k 0.7×	1.3k 0.4×	973 0.6×	291	10.7k

Countries citing papers authored by Jerome B. Zeldis

Since Specialization

Citations

This map shows the geographic impact of Jerome B. Zeldis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome B. Zeldis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome B. Zeldis more than expected).

Fields of papers citing papers by Jerome B. Zeldis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome B. Zeldis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome B. Zeldis. The network helps show where Jerome B. Zeldis may publish in the future.

Co-authorship network of co-authors of Jerome B. Zeldis

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome B. Zeldis. A scholar is included among the top collaborators of Jerome B. Zeldis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome B. Zeldis. Jerome B. Zeldis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact